Global Population Coupled with Advancement in Technology will drive the Implantable Cardioverter Defibrillators Market during the forecast period
Implantable Cardioverter-defibrillators Market
A small battery-operated device
called an implantable cardioverter-defibrillator is inserted into the body
(chest) and used to monitor and identify irregular heartbeats. It can fix an
abnormal heart rhythm by delivering electric shocks via one or more wires
connected to your heart. It is capable of cardioversion, defibrillation, and
heart rhythm and is typically attached to the heart with the aid of the thin
wires. Implantable cardioverter defibrillators with single, dual, and
biventricular chambers are some of the more popular models.
The implantable
cardioverter defibrillators market (ICDs) is anticipated to grow over
the course of the forecast period as a result of factors like the rising
prevalence of arrhythmia and rising demand for ICDs. In addition, expanding
ICD-related training and awareness programmes accelerate the market's
expansion. The implantable cardioverter defibrillator (ICD) market is expected
to experience slow growth in the coming years due to the possibility of
infection at the surgical site caused by the ICD implant.
On the other hand, technological
development and advancement are expected to open up more opportunities in the
near future for the expansion of the market for implantable cardioverter
defibrillators (ICDs).
The development of magnetic
resonance imaging (MRI)-safe implantable cardioverter defibrillators (ICDs) and
the introduction of quadripolar lead devices have all contributed to the
expansion of the market for implantable defibrillators. The demand for implantable
defibrillator devices is also fueled by an increase in atrial fibrillation
cases and the high risk of a sudden cardiac arrest (SCA). In addition, the 2012
introduction of subcutaneous ICD technology revolutionised the field of
treatment for controlling cardiac rhythm with these devices. Boston
Scientific's S-ICDs system, which was the first S-ICDs system in the world to
be commercially available, received market clearance in 2012. S-ICDs are widely
used because they can be implanted beneath the skin without the need for
heart-related leads.
Comments
Post a Comment